Drugs Health Pharma

Contineum’s test drug may reverse multiple sclerosis damage

Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.

Read More
Drugs Health Pharma

Opinion: Ocrevus takes a step forward in treating multiple sclerosis

By K. Leelamoni March 18, 2024: Akhila came up with a surprise statement while I was talking to her. “Mam’ I have multiple.

Read More
Climate Health Pharma

Environment, lifestyle behind epidemic of autoimmune diseases

HQ Team November 28, 2023: An escalating global crisis is unfolding as an increasing number of individuals grapple with autoimmune diseases, conditions wherein.

Read More
Drugs Health Pharma

USFDA green lights Sandoz’s biosimilar Tyruko to treat multiple sclerosis  

HQ Team August 25, 2023: The US drug regulator gave its nod for Sandoz Inc., an arm of Sweden-based Novartis and which is.

Read More
Drugs Health Pharma

Vaccine to treat Epstein-Brarr virus developed in mice

HQ Team August 17, 2023: A study on mice has produced a vaccine for Epstein-Barr virus, which is linked to a 32-fold higher.

Read More
Drugs Health Pharma

Cancer, multiple sclerosis, Ebola treatments in new WHO Essential Medicines List

HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to.

Read More
Drugs Health Pharma

Gene variant discovery may trigger new treatments for multiple sclerosis

HQ Team July 5, 2023: Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way.

Read More
Drugs Health Pharma

FDA applies brakes on Merck’s multiple sclerosis drug tests

HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its.

Read More
Drugs Pharma

Israeli firm Teva Pharmaceuticals under EC scanner

The EC has intimated Teva Pharmaceutical Industries, an Israel-based global company, of its "preliminary view" that it has breached EU antitrust rules by.

Read More
X